Human topoisomerase I mediates illegitimate recombination leading to DNA insertion into the ribosomal DNA locus in Saccharomyces cerevisiae

Molecular Genetics and Genomics

Volumn 271, Issue 3, 2004, Pages 347-358

  Zhu, J ^a,c   Schiestl, R H ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Functional Genetics Inc   (United States)

Author keywords

Genomic distribution; Genomic target sites; Human topoisomerase I; Nonhomologous recombination; Ribosomal DNA

Indexed keywords

DNA TOPOISOMERASE; RECOMBINANT DNA; RIBOSOME DNA;

ARTICLE; CONSENSUS SEQUENCE; DNA REPLICATION; DNA SEQUENCE; DNA TRANSCRIPTION; EUKARYOTE; GENE EXPRESSION; GENE INSERTION; GENE LOCUS; GENE SEQUENCE; GENOME; GERM CELL; LIVER; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; WHEAT; YEAST;

CAMPTOTHECIN; CONSENSUS SEQUENCE; DNA PRIMERS; DNA TOPOISOMERASES, TYPE I; DNA, FUNGAL; DNA, RIBOSOMAL; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, FUNGAL; HUMANS; RECOMBINATION, GENETIC; SACCHAROMYCES CEREVISIAE;

EUKARYOTA; INSERTION SEQUENCES; MAMMALIA; SACCHAROMYCES; SACCHAROMYCES CEREVISIAE; TRITICUM AESTIVUM;

EID: 2342538318     PISSN: 16174615     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00438-004-0987-7     Document Type: Article

References (51)

1. Alani E, Cao L, Kleckner N (1987) A method for gene disruption that allows repeated use of URA3 selection in the construction of multiply disrupted yeast strains. Genetics 116:541-545
2. Been MD, Burgess RR, Champoux JJ (1984) Nucleotide sequence preference at rat liver and wheat germ type 1 DNA topoisomerase breakage sites in duplex SV40 DNA. Nucleic Acids Res 12:3097-3114
3. Benedetti P, Fiorani P, Capuani L, Wang JC (1993) Camptothecin resistance from a single mutation changing glycine 363 of human DNA topoisomerase I to cysteine. Cancer Res 53:4343-4348
4. Bjornsti MA, Benedetti P, Viglianti GA, Wang JC (1989) Expression of human DNA topoisomerase I in yeast cells lacking yeast DNA topoisomerase I: restoration of sensitivity of the cells to the antitumor drug camptothecin. Cancer Res 49:6318-6323
5. Bjornsti MA, Knab AM, Benedetti P (1994) Yeast Saccharomyces cerevisiae as a model system to study the cytotoxic activity of the antitumor drug camptothecin. Cancer Chemother Pharmacol 34:S1-S5
6. Brill SJ, DiNardo S, Voelkel-Meiman K, Sternglanz R (1987a) DNA topoisomerase activity is required as a swivel for DNA replication and for ribosomal RNA transcription. NCI Monogr 4:11-15
7. Brill SJ, DiNardo S, Voelkel-Meiman K, Sternglanz R (1987b) Need for DNA topoisomerase activity as a swivel for DNA replication for transcription of ribosomal RNA. Nature 326:414-416 [Erratum appears in Nature (1987) 326:812]
8. Bullock P, Champoux JJ, Botchan M (1985) Association of crossover points with topoisomerase I cleavage sites: a model for nonhomologous recombination. Science 230:954-958
9. Champoux JJ (1976) Evidence for an intermediate with a single-strand break in the reaction catalyzed by the DNA untwisting enzyme. Proc Natl Acad Sci USA 73:3488-3491
10. Champoux JJ, Bullock PA (1988) Possible role for eukaryotic type I topoisomerase in illegitimate recombination. In: Kucherlapati R, Smith GR (eds) Genetic recombination. American Society for Microbiology, Washington D.C., pp 655-666
11. Christensen MO, Barthelmes HU, Boege F, Mielke C (2002) The N-terminal domain anchors human topoisomerase I at fibrillar centers of nucleoli and nucleolar organizer regions of mitotic chromosomes. J Biol Chem 277:35932-35938
12. Christman MF, Dietrich FS, Fink GR (1988) Mitotic recombination in the rDNA of S. cerevisiae is suppressed by the combined action of DNA topoisomerases I and II. Cell 55:413-425
13. Christman MF, Dietrich FS, Levin MA, Sadoff BU, Fink GR (1993) The rRNA-encoding DNA array has an altered structure in topoisomerase I mutants of Saccharomyces cerevisiae. Proc Natl Acad Sci USA 90:7637-7641
14. Craig NL (1988) The mechanism of conservative site-specific recombination. Annu Rev Genet 22:77-105
15. D'Arpa P, Liu LF (1989) Topoisomerase-targeting antitumor drugs. Biochim Biophys Acta 989:163-177
16. D'Arpa P, Machlin PS, Ratrie H III, Rothfield NF, Cleveland DW, Earnshaw WC (1988) cDNA cloning of human DNA topoisomerase I: catalytic activity of a 67.7-kDa carboxyl-terminal fragment. Proc Natl Acad Sci USA 852543-2547
17. DiNardo S, Voelkel K, Sternglanz R (1984) DNA topoisomerase II mutant of Saccharomyces cerevisiae: topoisomerase II is required for segregation of daughter molecules at the termination of DNA replication. Proc Natl Acad Sci USA 81:2616-2620
18. Eng WK, Faucette L, Johnson RK, Sternglanz R (1988) Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin. Mol Pharmacol 34:755-760
19. Eng WK, Pandit SD, Sternglanz R (1989) Mapping of the active site tyrosine of eukaryotic DNA topoisomerase I. J Biol Chem 264:13373-13376
20. Farabegoli F, Govoni M, Novello F (1992) Effects of camptothecin, an inhibitor of DNA topoisomerase I on ribosomal gene structure and function in TG cells. Biol Cell 74:281-286
21. Fleischmann G, Pflugfelder G, Steiner EK, Javaherian F, Howard GC, Wang JC, Elgin SC (1984) Drosophila DNA topoisomerase I is associated with transcriptionally active regions of the genome. Proc Natl Acad Sci USA 81:6958-6962
22. Gangloff S, Lieber MR, Rothstein R (1994) Transcription, topoisomerases and recombination. Experientia 50:261-269
23. Gietz RD, Sugino A (1988) New yeast- Escherichia coli shuttle vectors constructed with in vitro mutagenized yeast genes lacking six-base pair restriction sites. Gene 74:527-534.
24. Gietz D, St. Jean A, Woods RA, Schiestl RH (1992) Improved method for high efficiency transformation of intact yeast cells. Nucleic Acids Res 20:1425
25. Gilmour DS, Pflugfelder G, Wang JC, Lis JT (1986) Topoisomerase I interacts with transcribed regions in Drosophila cells. Cell 44:401-407
26. Goffeau A, et al (1996) Life with 6000 genes. Science 274:563-567
27. Hann C, Evans DL, Fertala J, Benedetti P, Bjornsti MA, Hall DJ (1998) Increased camptothecin toxicity induced in mammalian cells expressing Saccharomyces cerevisiae DNA topoisomerase I. J Biol Chem 273:8425-8433
28. Holm C, Covey JM, Kerrigan D, Pommier Y (1989) Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells. Cancer Res 49:6365-6368
29. Hsiang Y H, Liu LF (1988) Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin. Cancer Res 48:1722-1726
30. Hsiang YH, Hertzberg R, Hecht S, Liu LF (1985) Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J Biol Chem 260:14873-14878
31. Kim RA, Wang JC (1989) A subthreshold level of DNA topoisomerases leads to the excision of yeast rDNA as extrachromosomal rings. Cell 57:975-985
32. Knab AM, Fertala J, Bjornsti MA (1993) Mechanisms of camptothecin resistance in yeast DNA topoisomerase I mutants. J Biol Chem 268:22322-22330
33. Landy A (1989) Dynamic, structural, and regulatory aspects of lambda site-specific recombination. Annu Rev Biochem 58:913-949
34. Liu LF, D'Arpa P (1992) Topoisomerase-targeting antitumor drugs: mechanisms of cytotoxicity and resistance. Important Adv Oncol: 79-89
35. Nash H (1981) Site-specific recombination protein of phage λ. In: Boyer PD (ed) The Enzymes 14A:471-480
36. Nitiss J, Wang JC (1988) DNA topoisomerase-targeting antitumor drugs can be studied in yeast. Proc Natl Acad Sci USA 85:7501-7505
37. Olson MV (1991) Genome structure and organization in Saccharomyces cerevisiae. In: Broach JR, Jones EW, Pringle JR (eds) The molecular and cellular biology of the yeast Saccharomyces, vol 1. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., pp 1-39
38. Roth DB, Wilson JH (1986) Nonhomologous recombination in mammalian cells: role for short sequence homologies in the joining reaction. Mol Cell Biol 6:4295-4304
39. Rothenberg ML (1997) Topoisomerase I inhibitors: review and update. Ann Oncol 8:837-855
40. Schiestl RH, Gietz RD (1989) High efficiency transformation of intact yeast cells using single stranded nucleic acids as a carrier. Curr Genet 16:339-46
41. Schiestl RH, Petes TD (1991) Integration of DNA fragments by illegitimate recombination in Saccharomyces cerevisiae. Proc Natl Acad Sci USA 88:7585-7589
42. Schiestl RH, Dominska M, Petes TD (1993) Transformation of Saccharomyces cerevisiae with nonhomologous DNA: illegitimate integration of transforming DNA into yeast chromosomes and in vivo ligation of transforming DNA to mitochondrial DNA sequences. Mol Cell Biol 13:2697-2705
43. Shuman S (1989) Vaccinia DNA topoisomerase I promotes illegitimate recombination in Escherichia coli. Proc Natl Acad Sci USA 86:3489-3493
44. Tanizawa A, Kohn KW, Pommier Y (1993) Induction of cleavage in topoisomerase I cDNA by topoisomerase I enzymes from calf thymus and wheat germ in the presence and absence of camptothecin. Nucleic Acids Res 21:5157-5166
45. Tse-Dinh YC (1986) Uncoupling of the DNA breaking and rejoining steps of Escherichia coli type I DNA topoisomerase. Demonstration of an active covalent protein-DNA complex. J Biol Chem 261:10931-10935
46. Wang JC (1985) DNA topoisomerases. Annu Rev Biochem 54:665-697
47. Wang JC (1987) DNA topoisomerases: from a laboratory curiosity to a subject in cancer chemotherapy. NCI Monogr 4:3-6
48. Wang JC, Caron PR, Kim RA (1990) The role of DNA topoisomerases in recombination and genome stability: a double-edged sword? Cell 62:403-406
49. Wang LF, Ting CY, Lo CK, Su JS, Mickley LA, Fojo AT, Whang-Peng J, Hwang J (1997) Identification of mutations at DNA topoisomerase I responsible for camptothecin resistance. Cancer Res 57:1516-1522
50. Zhang H, Wang JC, Liu LF (1988) Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes. Proc Natl Acad Sci USA 85:1060-1064
51. Zhu J, Schiestl RH (1996) Topoisomerase I involvement in illegitimate recombination in Saccharomyces cerevisiae. Mol Cell Biol 16:1805-1812